Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Kiadis Pharma to present at upcoming investor conferences in March 2019 Amsterdam, The Netherlands, March 1, 2019 - Kiadis Pharma N.V. ("Kiadis...
-
Amsterdam, The Netherlands, 15 February 2019 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and...
-
Kiadis Pharma to participate in a panel at Innovation for Health 2019 Amsterdam, The Netherlands, February 11, 2019 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam...
-
Kiadis Pharma appoints Dr. Robert Friesen as Chief Scientific Officer Amsterdam, The Netherlands, and Boston, Massachusetts, USA...
-
Kiadis Pharma expands presence in the United States Scott Holmes commences position as chief financial officerAmy Sullivan appointed senior vice...
-
Kiadis Pharma to present at Biotech Showcase 2019 Amsterdam, The Netherlands, January 3, 2019 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: KDS), a...
-
Kiadis Pharma to present at upcoming investor conferences in November 2018 Amsterdam, The Netherlands, November 13, 2018 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext...
-
Amsterdam, The Netherlands, November 8, 2018 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: KDS), a clinical-stage...
-
Kiadis Pharma announces abstracts and presentations for the 60th American Society of Hematology (ASH) Annual Meeting Amsterdam,...
-
Not for release, publication or distribution, directly or indirectly, in or into the United States, Australia, Canada, Japan, south africa or Any other jurisdiction in which such release,...